Common use of Invention Rights Clause in Contracts

Invention Rights. 14.1. The Medical Center and the Principal Investigator hereby acknowledge that the idea and initiative for the Trial were exclusively those of BioCancell, and that the involvement of the Medical Center and the Principal Investigator in the Trial is strictly the consequence of their nomination by BioCancell. 14.2. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Confidential Information, except for medical records of the Subjects, is the exclusive property of BioCancell, may be freely utilized by BioCancell in any manner it sees fit. Notwithstanding the above, BioCancell shall have the right to review Subjects’ medical records to verify entries in the CRF’s. BioCancell hereby undertakes full responsibility to ensure the safekeeping of patients’ confidentiality and personal data and shall be fully responsible for taking every measure to apply this commitment. Template – agreement with medical centers 14.3. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Invention Rights shall be the absolute and exclusive property of BioCancell and that BioCancell shall have unrestricted free right to use such Invention Rights. 14.4. The Medical Center and the Principal Investigator hereby undertake to disclose to BioCancell any and all applicable information relating to Invention Rights and exercise their best efforts with regards to registration of the Inventions Rights on the name of BioCancell and/or a name designated in writing by BioCancell, if and to the extent requested to do so by BioCancell. 14.5. If by operation of law or for any reason, any Invention Rights to be owned by BioCancell pursuant to this Section 14 are not automatically deemed proprietary BioCancell upon their creation, the Medical Center and the Principal Investigator hereby further undertake to cause the Trial Personnel to, irrevocably grant and assign all such intellectual property rights to BioCancell. The Medical Center warrants that it has and will continue to have agreements with its personnel, including any Trial Personnel, to effectuate the terms of this section and it shall enforce such agreements to provide BioCancell with the benefit of this section.

Invention Rights. 14.1. The Medical Center and the Principal Investigator hereby acknowledge that the idea and initiative for the Trial were exclusively those of BioCancell, and that the involvement of the Medical Center and the Principal Investigator in the Trial is strictly the consequence of their nomination by BioCancell. 14.2. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Confidential Information, except for medical records of the Subjects, is the exclusive property of BioCancell, may be freely utilized by BioCancell in any manner it sees fit. Notwithstanding the above, BioCancell shall have the right to review Subjects’ medical records to verify entries in the CRF’s. BioCancell hereby undertakes full responsibility to ensure the safekeeping of patients’ confidentiality and personal data and shall be fully responsible for taking every measure to apply this commitment. Template Bnai Zion – agreement with medical centersfinal agreement 14.3. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Invention Rights shall be the absolute and exclusive property of BioCancell and that the BioCancell shall have unrestricted free right to use such Invention Rights. 14.4. The Medical Center and the Principal Investigator hereby undertake to disclose to BioCancell any and all applicable information relating to Invention Rights and exercise their best efforts with regards to registration of the Inventions Rights on the name of BioCancell and/or a name designated in writing by BioCancell, if and to the extent requested to do so by BioCancell. 14.5. If by operation of law or for any reason, any Invention Rights to be owned by BioCancell pursuant to this Section 14 are not automatically deemed proprietary BioCancell upon their creation, the Medical Center and the Principal Investigator hereby further undertake to cause the Trial Personnel to, irrevocably grant and assign all such intellectual property rights to BioCancell. The Medical Center warrants that it has and will continue to have agreements with its personnel, including any Trial Personnel, to effectuate the terms of this section and it shall enforce such agreements to provide BioCancell with the benefit of this section.

Invention Rights. 14.115.1. The Medical Center and the Principal Investigator hereby acknowledge that the idea and initiative for the Trial were exclusively those of BioCancell, and that the involvement of the Medical Center and the Principal Investigator in the Trial is strictly the consequence of their nomination by BioCancell.. Hadassah–agreement 0 Xxxxxx Xx, Xxxxxxxxx Xxxxxx 00000 Phone: +000-0-000-0000 Fax: +000-0-000-0000 xxx.xxxxxxxxxx.xxx xxxx@xxxxxxxxxx.xxx 14.215.2. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Confidential Information, except for medical records of the SubjectsSubjects and subject to Confidentiality, is the exclusive property of BioCancell, may be freely utilized by BioCancell in any manner it sees fit. Notwithstanding the above, BioCancell shall have the right to review Subjects’ medical records records, subject to the limitations stated in Section 8, to verify entries in the CRF’s. BioCancell hereby undertakes full responsibility to ensure the safekeeping of patients’ confidentiality and personal data and shall be fully responsible for taking every measure to apply this commitment. Template – agreement with medical centers. 14.315.3. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Invention Rights shall be the absolute and exclusive property of BioCancell and that BioCancell shall have unrestricted free right to use such Invention Rights. 14.415.4. The Medical Center and the Principal Investigator hereby undertake to disclose to BioCancell any and all applicable information relating to Invention Rights and exercise their best efforts with regards to registration of the Inventions Rights on the name of BioCancell and/or a name designated in writing by BioCancell, if and to the extent requested to do so by BioCancell and at BioCancell’s expense. 14.515.5. If by operation of law or for any reason, any Invention Rights to be owned by BioCancell pursuant to this Section 14 15 are not automatically deemed proprietary BioCancell upon their creation, the Medical Center and the Principal Investigator hereby further undertake to cause the Trial Personnel to, irrevocably grant and assign all such intellectual property rights to BioCancell, at BioCancell expense in relation to filling and submitting applications to the relevant authorities. 15.6. The Nothing contained herein shall be deemed to grant the Investigator and the Medical Center warrants that it has a license to use BioCancells’ Invention Rights and will continue to have agreements with its personnel, including IP for any purposes whatsoever except for the performance of the Trial Personnel, to effectuate the terms of this section and it shall enforce such agreements to provide BioCancell with the benefit of this sectionpursuant hereto.

Invention Rights. 14.1. The Medical Center Clinical Trial Site and the Principal Investigator hereby acknowledge that the idea and initiative for the Trial were exclusively those of BioCancell, and that the involvement of the Medical Center Clinical Trial Site and the Principal Investigator in the Trial is strictly the consequence of their nomination by BioCancell. 14.2. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Confidential Information, except for medical records of the Subjects, is the exclusive property of BioCancell, may be freely utilized by BioCancell in any manner it sees fit. Notwithstanding the above, BioCancell shall have the right to review Subjects’ medical records to verify entries in the CRF’sCRFs. BioCancell hereby undertakes full responsibility to ensure the safekeeping of patients’ confidentiality and personal data and shall be fully full responsible for taking every measure to apply this commitment. Template – agreement with medical centers. 14.3. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Invention Rights shall be the absolute and exclusive property of BioCancell and that BioCancell shall have unrestricted free right to use such Invention Rights. 14.4. The Medical Center Clinical Trial Site and the Principal Investigator hereby undertake to disclose to BioCancell any and all applicable information relating to Invention Rights and exercise their best efforts with regards to registration of the Inventions Rights on the name of BioCancell and/or a name designated in writing by BioCancell, if and to the extent requested to do so by BioCancell. 14.5. If by operation of law or for any reason, any Invention Rights to be owned by BioCancell pursuant to this Section 14 are not automatically deemed proprietary BioCancell upon their creation, the Medical Center Clinical Trial Site and the Principal Investigator hereby further undertake to cause the Trial Personnel to, to irrevocably grant and assign all such intellectual property rights to BioCancell. The Medical Center Clinical Trial Site warrants that it has and will continue to have agreements with its personnel, including any Trial Personnel, to effectuate the terms of this section and it shall enforce such agreements to provide BioCancell with the benefit of this section.

Invention Rights. 14.1. The Medical Center Fund and the Principal Investigator hereby acknowledge that the idea and initiative for the Trial were exclusively those of BioCancell, and that the involvement of the Medical Center Fund and the Principal Investigator in the Trial is strictly the consequence of their nomination by BioCancell. 14.2. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Confidential Information, except for medical records of the Subjects, is the exclusive property of BioCancell, may be freely utilized by BioCancell in any manner it sees fit. Notwithstanding the above, BioCancell shall have the right to review Subjects’ medical records to verify entries in the CRF’s. BioCancell hereby undertakes full responsibility to ensure the safekeeping of patients’ confidentiality and personal data and shall be fully responsible for taking every measure to apply this commitment. Template – agreement with medical centers. 14.3. The Parties parties and the Principal Investigator hereby irrevocably agree and undertake that the Invention Rights shall be the absolute and exclusive property of BioCancell and that BioCancell shall have unrestricted free right to use such Invention Rights. 14.4. The Medical Center Fund and the Principal Investigator hereby undertake to disclose to BioCancell any and all applicable information relating to Invention Rights and exercise their best efforts with regards to registration of the Inventions Rights on the name of BioCancell and/or a name designated in writing by BioCancell, if and to the extent requested to do so by BioCancell. 14.5. Template – agreement with Funds 8 Haxxxx Xx, Xxxxxxxxx Xxxxxx 00000 Xxxne: +972-0-000-0000 Xxx: +972-0-000-0000 xxx.xxxxxxxxxx.xxx xxxo@xxxxxxxxxx.xxx 00.5. If by operation of law or of for any reason, any Invention Rights to be owned by BioCancell pursuant to this Section 14 are not automatically deemed proprietary BioCancell upon their creation, the Medical Center Fund and the Principal Investigator hereby further undertake to cause the Trial Personnel to, irrevocably grant and assign all such intellectual property rights to BioCancell. The Medical Center Fund warrants that it has and will continue to have agreements with its personnel, including any Trial Personnel, to effectuate the terms of this section and it shall enforce such agreements to provide BioCancell with the benefit of this section.

Invention Rights. 14.1. The Medical Center and the Principal Investigator hereby acknowledge that the idea and initiative for the Trial were exclusively those of BioCancell, and that the involvement of the Medical Center and the Principal Investigator in the Trial is strictly the consequence of their nomination by BioCancell. 14.2. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Confidential Information, except for medical records of the Subjects, is the exclusive property of BioCancell, may be freely utilized by BioCancell in any manner it sees fit. Notwithstanding the above, BioCancell shall have the right to review Subjects’ medical records to verify entries in the CRF’s. BioCancell hereby undertakes full responsibility to ensure the safekeeping of patients’ confidentiality and personal data and shall be fully responsible for taking every measure to apply this commitment. Template – Meir-final agreement with medical centers0 Xxxxxx Xx, Xxxxxxxxx Xxxxxx 00000 Phone: +000-0-000-0000 Fax: +000-0-000-0000 xxx.xxxxxxxxxx.xxx xxxx@xxxxxxxxxx.xxx 14.3. The Parties and the Principal Investigator hereby irrevocably agree and undertake that the Invention Rights shall be the absolute and exclusive property of BioCancell and that BioCancell shall have unrestricted free right to use such Invention Rights. 14.4. The Medical Center and the Principal Investigator hereby undertake to disclose to BioCancell any and all applicable information relating to Invention Rights and exercise their best efforts with regards to registration of the Inventions Rights on the name of BioCancell and/or a name designated in writing by BioCancell, if and to the extent requested to do so by BioCancell. 14.5. If by operation of law or for any reason, any Invention Rights to be owned by BioCancell pursuant to this Section 14 are not automatically deemed proprietary BioCancell upon their creation, the Medical Center and the Principal Investigator hereby further undertake to cause the Trial Personnel to, irrevocably grant and assign all such intellectual property rights to BioCancell. The Medical Center warrants that it has and will continue to have agreements with its personnel, including any Trial Personnel, to effectuate the terms of this section and it shall enforce such agreements to provide BioCancell with the benefit of this section.